Skip to content
xylamidine

Structure via PubChem · Public domain (PubChem)

EntityQ8045338· pop 5· linked from 1,369 articles

xylamidine

Sign in to save

Xylamidine is a drug which acts as an antagonist of the serotonin 5-HT2A and 5-HT2C receptors, and to a lesser extent of the serotonin 5-HT1A receptor. The drug does not cross the blood–brain barrier and hence is peripherally selective, which makes it useful for blocking peripheral serotonergic responses like cardiovascular and gastrointestinal effects, without producing the central effects of 5-HT2A receptor blockade such as sedation, or interfering with the central actions of 5-HT2A receptor agonists.

Chemical data

Formula
C19H24N2O2
Molecular weight
312.4 g/mol
IUPAC name
N'-[2-(3-methoxyphenoxy)propyl]-2-(3-methylphenyl)ethanimidamide
SMILES
CC1=CC(=CC=C1)CC(=NCC(C)OC2=CC=CC(=C2)OC)N
InChIKey
JRYTUFKIORWTNI-UHFFFAOYSA-N
XLogP
3.3
Polar surface area
56.8 Ų
H-bond donors
1
H-bond acceptors
3
Formal charge
0

via PubChem

Drug data · ChEMBL

Max clinical phase
Phase 2
Molecule type
Small molecule

via ChEMBL · EBI

Wikidata facts

Has part
carbon
Mass
312.184
Show 4 more facts
chemical formula
C₁₉H₂₄N₂O₂
canonical SMILES
CC1=CC(=CC=C1)CC(=NCC(C)OC2=CC=CC(=C2)OC)N
isomeric SMILES
CC1=CC=CC(=C1)C/C(=N/CC(C)OC2=CC=CC(=C2)OC)/N
subject has role
serotonin antagonist
Sources (2)

via Wikidata · CC0

~2 min read

Encyclopedic overview

4 sections
Contents
  • Chemistry
  • Synthesis
  • See also
  • References

Xylamidine is a drug which acts as an antagonist of the serotonin 5-HT2A and 5-HT2C receptors, and to a lesser extent of the serotonin 5-HT1A receptor. The drug does not cross the blood–brain barrier and hence is peripherally selective, which makes it useful for blocking peripheral serotonergic responses like cardiovascular and gastrointestinal effects, without producing the central effects of 5-HT2A receptor blockade such as sedation, or interfering with the central actions of 5-HT2A receptor agonists.

Xylamidine and analogues were patented for use in combination with serotonin 5-HT2A receptor agonists like serotonergic psychedelics in 2023.

Excerpted from Wikipedia’s “xylamidine” article, available under the CC BY-SA 4.0 licence.

Available in 5 languages

via Wikidata sitelinks · CC0